Experience
In re Lumify
Bausch & Lomb Incorporated et al.
Slayback Pharma LLC et al.
Successfully represented Bausch & Lomb and Eye Therapies in a Hatch-Waxman patent infringement litigation and parallel PTAB challenges concerning an ANDA for generic versions of over-the-counter Lumify® ocular drops. The cases settled favorably for our clients.
Bausch & Lomb Incorporated et al. v. Slayback Pharma LLC et al., 3:21-cv-16766, D.N.J., Judges Kirsch, Singh
Bausch & Lomb Incorporated et al. v. Slayback Pharma LLC et al., IPR2022-00146, PTAB, Judges Hulse, New, Pollock
Bausch & Lomb Incorporated et al. v. Slayback Pharma LLC et al., IPR2024-00467, PTAB, Judges Flax, Pollock, Yang
Bausch & Lomb Incorporated et al. v. Slayback Pharma LLC et al., IPR2022-00142, PTAB, Judges Flax, Hulse, New, Pollock
Bausch Health Ireland Limited et al. v. Aurobindo Pharma Limited et al.
Bausch Health Ireland Limited et al.
Bausch & Lomb Incorporated; Bausch & Lomb Ireland Limited; Nicox, SA v. Gland Pharma Limited, et al.
Bausch & Lomb Incorporated et al.
Bausch Health Ireland Limited et al. v. Lupin Limited et al.
Bausch Health Ireland Limited et al.
Intellectual Ventures I LLC et al. v. Toyota Motor Corp. et al.
Toyota Motor Corp. et al.
Novartis Pharmaceuticals Corporation et al. v. Fresenius Kabi USA, LLC et al.
Novartis Pharmaceuticals Corporation et al.
Incyte Corporation et al. v. Sun Pharmaceutical Industries Limited et al.
Incyte Corporation et al.
Eidos Display, LLC et al. v. AU Optronics Corporation et al.
HannStar Display Corporation and Hannspree North America, Inc.
Uniloc USA, Inc. et al. v. Motorola Mobility LLC et al.
Motorola Mobility LLC et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.